Syndax Pharmaceuticals Falls 16.4% in Premarket Trading; SK hynix Down 5.1%

U.S. stock-index futures were mixed as technology shares faced pressure and investors awaited quarterly earnings from major banks.

BeCrypto News shows a short excerpt and links to the publisher. The full report belongs to TokenPost.